Method for treating premature ejaculation with a botulinum neurotoxin
AssigneeAllergan, Inc.
InventorsIvan Aguilar, Gustavo M. Gaxiola, Gilberto P. Paz
Life of this patent
Estimating the term…
Abstract
Methods for prolongation of climax time in a patient in need thereof are presented, as are methods for treating premature ejaculation by local administration of a Clostridial neurotoxin, such as botulinum neurotoxin, to the patient, are provided.
Claims17
A method for treating premature ejaculation in a patient in need thereof, the method comprising the step of locally administering a Clostridial neurotoxin to the patient in conjunction with an additional therapy for treating premature ejaculation, thereby treating premature ejaculation of the patient, wherein the Clostridial neurotoxin is a botulinum neurotoxin and is administered in an amount of from about 1 unit to 20,000 units.
A method for treating premature ejaculation in a patient in need thereof, the method comprising the step of locally administering by injection a botulinum neurotoxin to a penis of the patient in conjunction with an additional therapy for treating premature ejaculation, thereby treating premature ejaculation in the patient;
- wherein the locally administering is to at least one of a frenulum, a prepuce, a glans penis and a urethral opening of the penis.
A method for prolongation of climax time in a patient in need thereof, the method comprising the step of locally administering a botulinum neurotoxin to the patient in conjunction with an additional therapy for prolonging climax time, thereby prorogating climax time in the patient, wherein the Clostridial neurotoxin is a botulinum neurotoxin and is administered in an amount of from about 1 unit to 20,000 units.
Dependencies are inferred from the claim text.